Compounding

FDA extends comment period on GFI #256 to June 17, 2020.

0 comment(s)

UPDATE: February 14, 2020

 
In response to requests to extend the comment period for the revised draft guidance, “Compounding Animal Drugs from Bulk Drug Substances,” the FDA plans to provide an additional 120 days for the public to submit comments. The initial comment period is scheduled to end on February 18, 2020, but FDA will be reopening the comment period using the same docket number. Otherwise, the submission process remains unchanged.
 
The new deadline to receive comments will be June 17, 2020.
 

Horse Racing Integrity Act has 218 House sponsors

0 comment(s)

A majority of the U.S. House of Representatives has co-sponsored the Horseracing Integrity Act of 2019 (HIA).

 
The legislation now exceeds 218 co-sponsors, which is a majority of the 435 voting members of the House. The bill was introduced in the House by Reps. Paul Tonko (D-NY) and Andy Barr (R-KY).
 

NCPA Supports House Bill Strengthening Patient Access to Compounded Medications

0 comment(s)
ALEXANDRIA, Va. (June 21, 2017) National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in support of new compounding legislation, H.R. 2871, The Preserving Patient Access to Compounded Medications Act of 2017, introduced by Reps. Morgan Griffith (R-Va.) and Henry Cuellar (D-Texas), that will improve patient access to compounded medications:
   

IACP Applauds Bi-Partisan House Sponsors of HR 2871

0 comment(s)
IACP Logo
WASHINGTON – June 13, 2017 - The International Academy of Compounding Pharmacists (IACP) strongly supports new legislation, introduced by U.S. Congressmen Morgan Griffith (VA) and Henry Cuellar (TX), HR 2871 – The Preserving Patient Access to Compounded Medications Act of 2017, formally introduced on June 12, 2017. More than 300 compounding pharmacists traveled to Washington, D.C. on behalf of their patients and physicians to meet with their respective congressional representatives to discuss the Bill’s content, and to urge them to co-sponsor HR 2871.
  

Pages